
Lifecore Biomedical Inc.
LFCR · NASDAQ · Healthcare / Drug Manufacturers - Specialty & Generic
Price History
Full chartMarket Stats
About
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
Company Details
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CEOMr. Paul Josephs
- Employees382
- Headquarters3515 Lyman Boulevard, Chaska, MN, United States, 55318, USA
- Websitehttps://www.lifecore.com
Leadership
- Mr. Paul JosephsPresident, CEO & Director · b. 1966
- Mr. Ryan D. Lake CPAExecutive VP & CFO · b. 1977
- Mr. Thomas D. SalusChief Legal & Administration Officer and Corporate Secretary · b. 1970
- Mr. Thomas GuldagerSenior Vice President of Operations
- Mr. Aaron PerlitshDirector of Internal Audit & Chief Compliance Officer
- Ms. Jackie Q. KleckerExecutive Vice President of Quality & Development Services
- Mr. Mark DaFonsecaChief Commercial Officer
- Mr. Parker K. JavidVice President · b. 1969
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy2
- Hold1
Ownership Breakdown
- Institutions
- 77.30%
- Insiders
- 2.80%
- Retail / Other
- 19.90%
Top Institutional Holders
- Wynnefield Capital Inc4.70M12.42%
- Legion Partners Asset Management, LLC4.46M11.79%
- Greenhaven Road Investment Management, L.P.3.54M9.35%
- 325 Capital LLC2.90M7.65%
- BlackRock Inc1.88M4.96%
- Vanguard Capital Management, LLC1.29M3.41%
- Geode Capital Management, LLC815.11K2.15%
- Morgan Stanley - Brokerage Accounts764.73K2.02%
- State Street Corp642.01K1.70%
- Quinn Opportunity Partners LLC453.50K1.20%
- DCF Advisers, LLC424.50K1.12%
- Wittenberg Investment Management Inc314.01K0.83%
- Vanguard Fiduciary Trust Co237.06K0.63%
- Northern Trust Corp228.16K0.60%
- LPL Financial Corp207.79K0.55%
Top Fund Holders
- Vanguard MStar Total Stk Mkt Idx Invest822.11K2.17%
- iShares Russell 2000 ETF718.52K1.90%
- Fidelity Small Cap Index303.04K0.80%
- iShares Russell 2000 Value ETF237.75K0.63%
- Fidelity Extended Market Index188.71K0.50%